Pentoxifylline for blood vessel hardening in kidney disease
Treatments studied
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests if pentoxifylline, a medicine used for blood flow, can reduce calcium buildup in blood vessels for people with moderate-to-severe chronic kidney disease who are not yet on dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have chronic kidney disease (CKD) with an eGFR between 15 and 59.
- You are not currently having regular dialysis.
- You have not had a kidney transplant.
- You are not pregnant.
- You have not had coronary artery bypass surgery (CABG) and have no allergy to pentoxifylline.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether RVX000222 is safe and effective in people with end-stage kidney disease who receive hemodialysis. If you join, you’ll be carefully monitored to see how your body responds and whether it changes kidney-related health measures.
This study tests whether adding pentoxifylline to usual care can improve health outcomes in people with Eisenmenger syndrome. It may help reduce problems related to blood flow and vessel function, especially for those not recently hospitalized.
This study tests a generic version of the drug pentoxifylline (a tablet) to see if it works the same as the brand name. You will take the drug once and have blood samples taken over time. It's for healthy volunteers to help make sure the generic is safe and effective.
This trial tests whether adding pentoxifylline (a medication that improves blood flow) to your current psoriasis cream treatment helps reduce psoriasis patches. You'll be on stable topical therapy for at least 2 weeks, then the study will see if the added medication improves your skin.
This study tests if pentoxifylline, a medicine typically used for circulation, can help reduce joint inflammation in people with rheumatoid arthritis who still have active symptoms despite taking standard DMARDs.
This trial tests whether adding the medicine pentoxifylline to standard care can help people with ulcerative colitis. It’s designed to see if this combination improves symptoms by changing inflammation.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.